Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Evaluation01:15

Nursing Evaluation

4.6K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
4.6K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

4.2K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

515
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
515
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

1.0K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

196
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
196
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

936
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
936

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Exploratory Economic Evaluation of a Genome Precision Report in Kidney and Liver Transplantation Care.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Attitudes to mandatory COVID-19 vaccination in early life: findings from the multi-country cross-sectional CANDOUR study.

Health promotion international·2026
Same author

Who is waiting to see the surgeon? sociodemographic, clinical characteristics and previous osteoarthritis care of people with knee osteoarthritis referred to public hospitals in Victoria, Australia.

Osteoarthritis and cartilage open·2026
Same author

Characterizing Disparities in GLP-1 Receptor Agonist Use Among US Adults With and Without Diabetes.

Journal of general internal medicine·2026
Same author

Supported implementation enhances injury prevention programme (Prep-to-Play) use in women and girls playing Australian Football: a pragmatic type III hybrid implementation-effectiveness stepped wedge cluster randomised trial.

British journal of sports medicine·2026
Same author

Public preferences for saving lives versus life-years: evidence from a person-trade-off experiment in 12 countries during the COVID-19 pandemic.

The European journal of health economics : HEPAC : health economics in prevention and care·2026

Related Experiment Video

Updated: Mar 10, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K

Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right.

Chris Schilling1, Michelle M Dowsey2, Philip M Clarke3

  • 1Centre for Health Policy, School of Population and Global Health, the University of Melbourne, Carlton, Victoria, Australia; The University of Melbourne Department of Surgery, St. Vincent's Hospital, Fitzroy, Victoria, Australia.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|December 19, 2016
PubMed
Summary

Collecting patient-reported outcomes (PROMs) for total knee arthroplasty at 3 months postoperatively minimizes bias in quality-adjusted life-year (QALY) estimation. Early or late measurements significantly skew economic evaluation results.

Keywords:
PROMseconomic evaluationtimingtotal knee arthroplasty

More Related Videos

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

1.6K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Related Experiment Videos

Last Updated: Mar 10, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K
Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

1.6K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Area of Science:

  • Orthopedic Surgery
  • Health Economics
  • Biostatistics

Background:

  • Patient-reported outcome measures (PROMs) are increasingly vital in orthopedic surgery for economic evaluations.
  • Generic quality-of-life instruments like the SF-12 are used to estimate quality-adjusted life-years (QALYs).
  • The optimal timing for postoperative PROM collection remains debated, potentially impacting economic analyses.

Purpose of the Study:

  • To investigate the impact of different postoperative PROM collection timings on QALY estimation bias.
  • To determine the optimal time point for postoperative PROM collection in total knee arthroplasty (TKA) for accurate economic evaluation.

Main Methods:

  • Compared QALY estimation accuracy using SF-12 data collected at 6 weeks, 3 months, 6 months, and 12 months post-TKA.
  • Utilized 5-year follow-up data from the St. Vincent's Melbourne Arthroplasty Outcomes (SMART) registry (n=484).
  • Analyzed data under various interpolation methods between measurement points.

Main Results:

  • Postoperative PROM collection at 6 weeks, 6 months, or 12 months resulted in significant QALY estimation bias (-41%, 18%, -8% respectively).
  • Collecting PROMs at 3 months postoperatively minimized bias, showing only a 6% error.
  • Confidence intervals indicated the statistical significance of the observed biases.

Conclusions:

  • The timing of PROM collection and interpolation methods critically influence economic evaluation bias in TKA.
  • A postoperative PROM measurement at 3 months, with linear interpolation, is recommended for TKA economic evaluations.
  • Future economic evaluations should carefully consider the timing and interpolation assumptions for PROM data.